BM, BCH, MA, MRCGP, DPhil
Professor of Evidence-Based Medicine
- Director of CEBM & Programs in EBHC
- Editor in Chief, BMJ EBM
- NHS Urgent Care GP
- NIHR Senior Investigator
Carl Heneghan is a clinical epidemiologist with expertise in evidence-based medicine, research methods, and evidence synthesis.
He is Director of the NIHR SPCR Evidence Synthesis Working Group a collaboration of nine primary care departments across UK universities. He set up and directs the Oxford COVID Evidence Service, has over 400 peer-reviewed publications (current H Index 67); published 95 systematic reviews. He is Editor in Chief of BMJ Evidence-Based Medicine, and Editor of the Catalogue of Bias,
His work includes investigating drugs and devices, advising governments on regulatory evidence, working with the media assessing health claims and research on common presenting conditions in primary care, including work on acute respiratory infections and antivirals Tamiflu.
He has investigated the evidence for sports drinks, IVF 'add-on' treatments, metal-hips, cancer screening, health-checks, surgical mesh, medical devices and hormone pregnancy tests. He has worked in diagnosis and is a lead for the Preventing Overdiagnosis Conference.
He is a clinical advisor to two UK All Parliamentary Party Group on Surgical Mesh and Hormone Pregnancy Tests, and A founder of the AllTrials campaign twice voted one of the top 100 NHS clinical leaders by the HSJ. In 2018 he was awarded NIHR Senior Investigator status.
In 2019 he received a lifetime achievement award from Oxford's Medical Science Division for his sustained commitment to education and teaching. He is Director of the Centre for Evidence-Based Medicine (CEBM), which builds capacity through teaching and training activities. He teaches undergraduates, postgraduates and teachers of EBM, and is Director of Programs in Evidence-Based Health Care,
Dissemination and Media: See find an expert page
The BMJ Talk Evidence podcast: Duncan Jarvies, Helen Macdonald and Carl Heneghan – with occasional guests- discuss what’s been happening in the world of evidence.
He has over 400 peer-reviewed publications (current H Index 67) and co-authored the EBM toolkit and Statistics Toolkit (BMJ-Blackwell’s) and, developed the EvidenceLive conference, now in its 10th year.
Conflicts of interest and payments:
Carl has received expenses and fees for his media work (including payments from BBC Radio 4 Inside Health). He has received expenses from the WHO, FDA, and holds grant funding from the NIHR, the NIHR School of Primary Care Research. The NIHR BRC Oxford and the WHO. He has received financial remuneration from an asbestos case and to date has given legal advice on mesh and hormone pregnancy tests cases. He has also received income from the publication of a series of toolkit books published by Blackwells and funding for appraising evidence for treatment recommendations in NHS and non-NHS settings. On occasion, he receives expenses for teaching EBM and is also paid for his GP work in NHS out of hours (contract Oxford Health NHS Foundation Trust). He is Director of CEBM, which jointly runs the EvidenceLive Conference with the BMJ and the Overdiagnosis Conference with international partners, based on a non-profit making model. He is Editor in Chief of BMJ Evidence-Based Medicine and is an NIHR Senior Investigator.
Brodersen J. et al, (2018), BMJ evidence-based medicine, 23, 1 - 3
Nunan D. et al, (2017), BMJ Evidence-based medicine
Hayward GN. et al, (2017), Journal of the American Medical Association
Effect of antihypertensive medication reduction vs usual care on short-term blood pressure control in patients aged ≥ 80 years with hypertension
SHEPPARD J. et al, (2020), JAMA: Journal of the American Medical Association
Bradbury C. et al, (2020), Br J Haematol, 188, 962 - 975
Pluddemann A. and Heneghan C., (2020), BMJ Evid Based Med